Hyaluronic acid 0.2 % cream for preventing radiation dermatitis in breast cancer patients treated with postoperative radiotherapy: A randomized, double-blind, placebo-controlled study

Hyaluronic acid 0.2 % cream for preventing radiation dermatitis in breast cancer patients treated with postoperative radiotherapy: A randomized, double-blind, placebo-controlled study

Introduction: This randomized trial evaluated the efficacy and safety of the prophylactic use of a hyaluronic acid (HA) 0.2 %-containing cream to reduce acute radiodermatitis in breast cancer patients undergoing adjuvant radiotherapy (RT). Methods: Candidates for conventionally-fractionated or hypof...

Full description

Saved in:
Bibliographic Details
Main Authors: Letizia Deantonio, Giulia Borgonovo, Serena Caverzasio, Maria Antonietta Piliero, Paola Canino, Andrea Puliatti, Thomas Zilli, Maria Carla Valli, Antonella Richetti
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Breast
Subjects:
Breast cancer
Radiotherapy
Acute radiation dermatitis
Skin toxicity
Patients reported outcomes
Hyaluronic acid
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977625005302
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S0960977625005302

Similar Items